Raiffeisen Bank International’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Hold
200
﹤0.01% 508
2026
Q1
$184K Hold
200
﹤0.01% 493
2025
Q4
$182K Hold
200
﹤0.01% 475
2025
Q3
$153K Buy
+200
New +$149K ﹤0.01% 480

Other funds holding LLY

Raiffeisen Bank International's LLY Position: Q2 2026 in Review

Raiffeisen Bank International reduced its Eli Lilly (LLY) stake by 4.8% in Q2 2026, selling an estimated $6.71M and leaving 129,513 shares worth $159M. The position accounts for 1.87% of the portfolio, ranked #8.

Raiffeisen Bank International first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Raiffeisen Bank International held 129,513 shares of Eli Lilly worth $159M as of Q2 2026.
  • Raiffeisen Bank International sold 6,567 Eli Lilly shares in Q2 2026, an estimated $6.71M.
  • Eli Lilly made up 1.87% of Raiffeisen Bank International's portfolio in Q2 2026, its #8 holding.
  • Raiffeisen Bank International first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.